Press Releases - 2023-01-19

Date	Title	Company
19-Jan-2023	NETRIS Pharma led consortium awarded €1.2 million Eurostar grant to explore netrin-1 targeted therapeutics	Netris Pharma
19-Jan-2023	Transcatheter Aortic Valve System Market is expected to register a CAGR of 11% from 2023 to 2032 \| insightSLICE	insightSLICE
19-Jan-2023	Micrographic Camera Market is projected to accelerate at a CAGR of 5.2% from 2023 to 2032 \| insightSLICE	insightSLICE
19-Jan-2023	Feminine Hygiene Product Machine Market Expand at a CAGR of 5.2% from 2023 to 2032 \| insightSLICE	insightSLICE
19-Jan-2023	Digital Applanation Tonometer Market is expected to grow at a CAGR of 7.2% by 2032 \| insightSLICE	insightSLICE
19-Jan-2023	Biostimulants Market is expected to register a CAGR of 10.5% from 2023 to 2032 \| insightSLICE	insightSLICE
19-Jan-2023	Binocular Biological Microscope Market is expected to register a CAGR of 3.2% by 2032 \| insightSLICE	insightSLICE
19-Jan-2023	osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer	osteolabs
19-Jan-2023	SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab	SOTIO Biotech
19-Jan-2023	Cool & homogeneous: Single Use Support introduces product innovation	Single Use Support
19-Jan-2023	Trial and Error - do our clinical trials match the ages of those who need medicines most?	International Longevity Centre (ILC)
19-Jan-2023	NICE recommends all-oral triplet regimen for patients living with relapsed or refractory multiple myeloma	Takeda UK Ltd.
19-Jan-2023	AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease	AC Immune
19-Jan-2023	osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer	B3C newswire
19-Jan-2023	SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab	B3C newswire
19-Jan-2023	NICE recommends AMVUTTRA®▼ (vutrisiran) as treatment for a hereditary form of amyloidosis in draft guidance	Alnylam Pharmaceuticals
19-Jan-2023	TrakCel and AmerisourceBergen expand platform integration to facilitate patient care coordination for cell and gene therapies	TrakCel
19-Jan-2023	Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium	– Servier and Taiho Oncology, Inc.
19-Jan-2023	NeoPhore completes extension to Series B financing to further advance discovery pipeline	NeoPhore Limited
19-Jan-2023	HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China	HUTCHMED